BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbarawi M, Zayed Y, Kheiri B, Gakhal I, Barbarawi O, Bala A, Alabdouh A, Abdalla A, Rizk F, Bachuwa G, Katato K. The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials. Thromb Res 2019;181:36-45. [PMID: 31349093 DOI: 10.1016/j.thromres.2019.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-garcía LA, Bounameaux H, Pabinger I, Douketis J, Ageno W, Ajauro F, Alcindor T, Angchaisuksiri P, Arcelus JI, Barba R, Bazarbachii A, Bellesoeur A, Bensaoula O, Benzidia I, Bita D, Bitsadze V, Blickstein D, Blostein M, Bogalho I, Brandao A, Calado R, Carpentier A, Ceresetto JM, Chitsike R, Connault J, Correia CJ, Crichi B, De Paula EV, Demir AM, Deville L, Doucet L, Dounaevskaia V, Durant C, Ellis M, Emmerich J, Falanga A, Font C, Gallardo E, Gary T, Gonçalves F, Gris J, Hayashi H, Hij A, Jara-palomares L, Jiménez D, Khizroeva J, N'guessan M, Langer F, Le Hello C, Le Maignan C, Lecumberri R, Lee LH, Liederman Z, Lopes dos Santos L, Machado DH, Makatsariya A, Maneyro A, Marjanovic Z, Milhaileanu S, Monreal M, Morais S, Moreira A, Mukai M, Ndour A, Correa Oliveira L, Otero-candelara R, Tostes Pintao MC, Posch F, Prilollet P, Rafii H, Dias Ribeiro D, Riess H, Righini M, Robert-ebadi H, Rothschild C, Roussin A, Rueda Camino JA, Ruiz-artacho P, Saharov G, Santos J, Sebuhyan M, Shamseddine A, Spectre GS, Taher A, Trujillo-santos J, Tzoran I, Villiers S, Wong R, Yamashita Y, Yannoutsos A, Yasuda C. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. The Lancet Oncology 2022;23:e334-47. [DOI: 10.1016/s1470-2045(22)00160-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Liang B, Liang Y, Zhao LZ, Zhao YX, Gu N. Rivaroxaban for cancer-associated venous thromboembolism. Sci Prog 2021;104:368504211012160. [PMID: 33913387 DOI: 10.1177/00368504211012160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hsieh KY, Tsai JY, Lin YH, Chang FR, Wang HC, Wu CC. Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells. Sci Rep 2021;11:4610. [PMID: 33633307 DOI: 10.1038/s41598-021-84207-8] [Reference Citation Analysis]
4 Pizzuti L, Krasniqi E, Mandoj C, Marinelli D, Sergi D, Capomolla E, Paoletti G, Botti C, Kayal R, Ferranti FR, Sperduti I, Perracchio L, Sanguineti G, Marchetti P, Ciliberto G, Barchiesi G, Mazzotta M, Barba M, Conti L, Vici P. Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial. Cancers (Basel) 2020;12:E849. [PMID: 32244657 DOI: 10.3390/cancers12040849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zabrocka E, Sierko E. Thromboprophylaxis in the End-of-Life Cancer Care: The Update. Cancers (Basel) 2020;12:E600. [PMID: 32150978 DOI: 10.3390/cancers12030600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]